Agilent Technologies, Inc.
New York Stock Exchange•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.Company Description
- CEO
- Mr. Padraig McDonnell
- Full Time Employees
- 17,900
- Sector
- Healthcare
- Industry
- Medical - Diagnostics & Research
- Address
- 5301 Stevens Creek Boulevard Santa Clara CA United States of America 95051
- IPO Date
- Nov 18, 1999
- CIK
- 0001090872
- Website
- agilent.com
- Similar Companies
- Business
- Agilent Technologies, Inc. provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; vacuum pumps, and measurement technologies. The Diagnostics and Genomics segment provides arrays for DNA mutation detection, genotyping, gene copy number determination, identification of gene rearrangements, DNA methylation profiling, gene expression profiling, next generation sequencing, target enrichment and genetic data management, and interpretation support software; and produces synthesized oligonucleotide. It also offers immunohistochemistry in situ hybridization, and hematoxylin and eosin staining and special staining; consumables, and software for quality control analysis of nucleic acid samples; and reagents for use in turbidimetry and flow cytometry, as well as develops liquid-based pharmacodiagnostics. The Agilent CrossLab segment provides GC and LC columns, sample preparation products, custom chemistries, and laboratory instrument supplies; and startup, operational, training, compliance support, software as a service, asset management, and consultation services. The company markets its products through direct sales, distributors, resellers, manufacturer's representatives, and electronic commerce. Agilent Technologies, Inc. was incorporated in 1999 and is headquartered in Santa Clara, California.
Company News
Agilent to Showcase New Products and Innovations at HPLC 2025
Agilent Technologies, Inc. (A) Jefferies Global Healthcare Conference - (Transcript)
Don't Overlook Agilent (A) International Revenue Trends While Assessing the Stock
Agilent Q2 Earnings Beat Estimates, Revenues Up Y/Y, Shares Rise
Agilent Technologies, Inc. (A) Q2 2025 Earnings Conference Call Transcript
Here's What Key Metrics Tell Us About Agilent (A) Q2 Earnings
Agilent Technologies (A) Q2 Earnings and Revenues Top Estimates
Life sciences firm Agilent beats quarterly estimates on instrument demand
Agilent Reports Second-Quarter Fiscal Year 2025 Financial Results
Agilent Names August Specht as Chief Technology Officer
Agilent Announces the Enhanced 8850 Gas Chromatograph: Compact, Powerful, and Now Mass Spec-Connected for Superior Analytical Performance
Agilent Unveils the Next Generation in LC-Mass Detection: The InfinityLab Pro iQ Series
Curious about Agilent (A) Q2 Performance? Explore Wall Street Estimates for Key Metrics
Agilent Announces Cash Dividend of 24.8 Cents per Share
Pascal Soriot and Judy Gawlik Brown Named to Agilent Board of Directors
Agilent Announces My Green Lab Ecolabel 2.0 for the New Infinity III LC Series
Agilent to Participate in Jefferies Global Healthcare Conference
Scale Has Its Advantages: 3 A-Rated REIT Monopolies
Will Agilent (A) Beat Estimates Again in Its Next Earnings Report?
The Preferred Stock IPO Market Is Frozen